{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.6","upperLimit":"5.3","value":"2.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"description":"Median length of response in months.","dispersionType":"Full Range","groups":[{"description":"Subject will take tadalafil in combination with with Lenalidomide and dexamethasone (Rd) or Clarithromycin/Lenalidomide/ dexamethasone (BiRd)\n\nTadalafil: Tadalafil will be administered at a dose of 20 mg orally daily starting with day 1 of the first cycle. Each cycle will last for 28 days\n\nLenalidomide: Lenalidomide will be administered as it was prior to study entry.\n\nDexamethasone: Dexamethasone will be administered as it was prior to study entry.\n\nClarithromycin: Clarithromycin will be administered as it was prior to study entry.","id":"OG000","title":"Tadalafil"}],"paramType":"MEDIAN","populationDescription":"This analysis only includes the 5 participants who had a clinical response.","reportingStatus":"POSTED","timeFrame":"Up to 6 months","title":"Duration of Response","type":"SECONDARY","unitOfMeasure":"months"}